Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma

Frank Eckerdt*, Jessica Clymer, Jonathan B. Bell, Elspeth M. Beauchamp, Gavin T. Blyth, Stewart Goldman, Leonidas C. Platanias

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences